Building Blocks

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>1-Sulfamoylcyclopropane-1-carboxylic acid is a cycloalkylating agent that reacts with nucleophiles to form alkylated products. It is an analog of the naturally occurring amino acid cysteine and can be used as a substitute for this amino acid in some reactions. 1-Sulfamoylcyclopropane-1-carboxylic acid has been shown to react with nucleophiles at a rate that is 10 times faster than natural cysteine, making it more reactive. This product can be used in the synthesis of sulfonamides, which are drugs used to treat bacterial infections. The sulfonamide group reacts with the thiol groups on bacteria's cell walls and inhibits their growth by preventing bacterial synthesis of proteins and DNA.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

Versatile small molecule scaffold

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>1-[4-(Ethylsulfonyl)phenyl]methanamine is a molecule that can be used as a cancer therapeutic. It has been shown to increase the expression of retinoic acid-related transcription factors, which in turn upregulates the expression of genes involved in cell cycle arrest and apoptosis. 1-[4-(Ethylsulfonyl)phenyl]methanamine has immunomodulatory and anti-inflammatory activities, which may be due to its ability to induce Th17 cells. The molecule binds to amine moieties on proteins, including transcription factors and enzymes. This binding leads to inhibition of transcriptional activity and enzyme activity, respectively.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>3-Fluoro-5-nitrobenzamide (3FNBA) is a potent and selective inhibitor of mammalian trypanosomal 3-ketoacyl-CoA synthase, which is an enzyme involved in the biosynthesis of lipids. 3FNBA has been shown to have significant activity against Trypanosoma brucei, with inhibitory potency that is 10 times higher than that of suramin. 3FNBA also has selectivity for mammalian cells over bacterial and yeast cells. The discovery of this drug was made through the screening of a group of compounds for their ability to inhibit mammalian trypanosomal 3-ketoacyl-CoA synthase.</p>

Versatile small molecule scaffold

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>2-Bromo-1,4-difluoro-3-methoxybenzene (BDFMB) is a radiolabeled metabotropic glutamate receptor 2 (mGlu2) allosteric modulator. BDFMB has been shown to have affinity for the mGlu2 receptor and is able to increase the binding of glutamate to this receptor. This drug may be useful in clinical studies as a radiotracer for imaging mGlu2 receptors in the brain. It has also been shown to be an allosteric modulator of the mGlu2 receptor, which may provide a new therapeutic option for treating depression and other disorders that are thought to involve mGlu2 receptors.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>3-(1H-Imidazol-2-yl)propanoic acid hydrochloride is a potent inhibitor of the GABA transporter. It is an imidazole derivative with a 3-substituted propanoic acid moiety and a protonated imidazole ring. The compound inhibits the GABA transporter, which is responsible for transporting GABA into presynaptic neurons and glia cells. This inhibitory effect blocks the function of the transporter proteins, leading to decreased levels of GABA in the brain, which leads to increased levels of gaba in the synapse. 3-(1H-Imidazol-2-yl)propanoic acid hydrochloride has been shown to have potent inhibitory effects on a number of other neurotransmitter transporters, including glutamate and glycine transporters.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

Versatile small molecule scaffold

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

Versatile small molecule scaffold

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>2-Pyridyl-4-methylthiazole-5-carboxylic acid is a ligand that can be used to study the molecular orbitals of coordination complexes. The ligand binds to metal ions and forms metalloproteins, which are compounds that contain metals and proteins. 2-Pyridyl-4-methylthiazole-5-carboxylic acid has been shown to form dinuclear complexes with metal ions such as rhenium, which are important for chemical processes including catalytic reactions. The ligand also has an electron configuration that is similar to those of molecules in the group 18 elements in the periodic table, making it a good candidate for studying the electronic structure of these elements. X-ray crystallography studies have shown that this ligand binds to a metal ion at one end and coordinates with two other atoms at the other end. Functional theory calculations have been used to elucidate the electronic spectrum of this ligand.</p>

<p>2-Azatricyclo[7.3.0.0,3,7]dodeca-1,3(7),8-triene is a mesoporous material with three dimensional channels that can adsorb molecules such as formaldehyde and pyridine. The zeolites in this material have been shown to catalyze the conversion of formaldehyde to methanol by reacting with a transition metal ion and a thioamide. This material has also been shown to be able to adsorb metal ions such as copper and zinc from solutions using its porous structure. 2-Azatricyclo[7.3.0.0,3,7]dodeca-1,3(7),8-triene can be used as a catalyst for the removal of toxic substances from water or air, or as a selective adsorbent for the separation of metal ions in industrial processes.</p>

<p>Methyl(nitroso)octylamine (MNTOA) is a chemical that is used in animal research to induce cancer. MNTOA acts by nitrosating DNA, which induces mutations and leads to the formation of cholangiocarcinomas in rats. It also interacts with other molecules in the body, such as bladder proteins and hemoglobin, leading to an increased risk of death. MNTOA has been shown to be carcinogenic in animals, inducing tumors in the nasal cavity and bladder. The carcinogenicity of MNTOA may be caused by its ability to damage DNA through nitrosation reactions.</p>

<p>2-(4-Chlorobenzamido)benzoic acid is a symmetric dimer with a hydrogen bond between the two benzene rings. The hydrogen bond is formed by the substituent on one benzene ring interacting with the hydrogen on the other one. The molecule has a conformation that allows it to form hydrogen bonds and is centrosymmetric. 2-(4-Chlorobenzamido)benzoic acid has been synthesized from benzaldehyde and substituted amides, which are synthons for an amide linkage. It crystallizes as a centrosymmetric dimer in space group P2(1)2(1).</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>